Experimental and clinical application of plasmid DNA in the field of central nervous diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Gene Therapy

• Publication date

  2011-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156652311798192833PMID 22023479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Therapy in Parkinson’s Disease

  2010cited by this paper
• Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats.

  2010cited by this paper
• Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies.

  2010cited by this paper
• CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease.

  2010cited by this paper
• Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons

  2009cited by this paper
• Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

  2009cited by this paper
• VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia.

  2009cited by this paper
• Molecular and cellular mechanisms of DNA vaccines

  2008cited by this paper
• DNA vaccines: ready for prime time?

  2008cited by this paper
• Alleviation of Aβ-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model

  2008cited by this paper
• Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis

  2008cited by this paper
• Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy

  2008cited by this paper
• Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System

  2008cited by this paper
• Novel Liposomal Formulation for Targeted Gene Delivery

  2007cited by this paper
• Comparison of cDNA and genomic forms of tyrosine hydroxylase gene therapy of the brain with Trojan horse liposomes

  2007cited by this paper
• Gene Vaccination for the Induction of Immune Tolerance

  2007cited by this paper
• VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion

  2007cited by this paper
• A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.

  2007cited by this paper
• Nerve Growth Factor Gene Therapy in Alzheimer Disease

  2007cited by this paper
• Gene Transfer of Hepatocyte Growth Factor Gene Improves Learning and Memory in the Chronic Stage of Cerebral Infarction

  2006cited by this paper
• Prevention of onset of Parkinson’s disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson’s disease

  2006cited by this paper
• Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide.

  2006cited by this paper
• Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.

  2006cited by this paper
• Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles

  2005cited by this paper
• Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.

  2005cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.

  2004cited by this paper
• Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism with Intravenous Nonviral Gene Therapy and a Brain-Specific Promoter

  2004cited by this paper
• Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound

  2004cited by this paper
• Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils

  2004cited by this paper
• New roles for VEGF in nervous tissue--beyond blood vessels.

  2004cited by this paper
• Novel Therapeutic Strategy to Treat Brain Ischemia: Overexpression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury Without Cerebral Edema in Rat Model

  2004cited by this paper
• Effect of Brain-Derived Neurotrophic Factor Treatment and Forced Arm Use on Functional Motor Recovery After Small Cortical Ischemia

  2004cited by this paper
• Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia.

  2004cited by this paper
• Organ‐specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice

  2004cited by this paper
• Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccination.

  2004cited by this paper
• Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.

  2003cited by this paper
• Intravenous Nonviral Gene Therapy Causes Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism

  2003cited by this paper
• Suppressive DNA Vaccination in Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis Involves a T1-Biased Immune Response 1

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Exogenous expression of hepatocyte growth factor (HGF) in rat striatum by naked plasmid DNA.

  2003cited by this paper
• VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.

  2003cited by this paper
• Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.

  2003cited by this paper
• Global non-viral gene transfer to the primate brain following intravenous administration.

  2003cited by this paper
• Intraventricular Infusion of Vascular Endothelial Growth Factor Promotes Cerebral Angiogenesis with Minimal Brain Edema

  2002cited by this paper
• Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle

  2002cited by this paper
• Gene Transfer of Hepatocyte Growth Factor to Subarachnoid Space in Cerebral Hypoperfusion Model

  2002cited by this paper
• Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound.

  2002cited by this paper
• Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons

  2001cited by this paper
• Brain-specific expression of an exogenous gene after i.v. administration

  2001cited by this paper
• Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats

  2001cited by this paper
• VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.

  2000cited by this paper
• Rescue of ischemic brain injury by adenoviral gene transfer of glial cell line-derived neurotrophic factor after transient global ischemia in gerbils.

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.

  2000cited by this paper
• Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis.

  2000cited by this paper
• Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.

  2000cited by this paper
• Expression of angiogenic factors in rabbit spinal cord after transient ischaemia

  1999cited by this paper
• Clinical applications of angiogenic growth factors and their inhibitors

  1999cited by this paper
• Effective administration route for the deleted form of hepatocyte growth factor To exert its pharmacological effects.

  1999cited by this paper
• Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device.

  1999cited by this paper
• Intradermal DNA immunization by using jet-injectors in mice and monkeys.

  1999cited by this paper
• Protection of Hippocampal Neurons from Ischemia-Induced Delayed Neuronal Death by Hepatocyte Growth Factor: A Novel Neurotrophic Factor

  1998cited by this paper
• Vaccination with DNA Encoding an Immunodominant Myelin Basic Protein Peptide Targeted to Fc of Immunoglobulin G Suppresses Experimental Autoimmune Encephalomyelitis

  1998cited by this paper
• Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.

  1998cited by this paper
• Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion.

  1998cited by this paper
• Ameliorative effect of glial cell line-derived neurotrophic factor on brain edema formation after permanent middle cerebral artery occlusion in rats.

  1998cited by this paper
• Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system.

  1998cited by this paper
• Alzheimer's disease: genotypes, phenotypes, and treatments.

  1997cited by this paper
• Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion.

  1997cited by this paper
• Gene transfer by naked DNA into adult mouse brain.

  1996cited by this paper
• VEGF and flt. Expression time kinetics in rat brain infarct.

  1996cited by this paper
• Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor.

  1995cited by this paper
• Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA.

  1995cited by this paper
• GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo.

  1995cited by this paper
• Animal models

  1994cited by this paper
• Expression and functional interaction of hepatocyte growth factor- scatter factor and its receptor c-met in mammalian brain

  1994cited by this paper
• Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen.

  1994cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Brain‐derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5‐trihydroxyphenylalanine‐induced injury

  1993cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• Brain-derived neurotrophic factor prevents neuronal death in vivo

  1988cited by this paper
• Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

  1984cited by this paper

• From genome to epigenome: Who is a predominant player in the molecular hallmarks determining epigenetic mechanisms underlying ontogenesis?

  2024cites this paper
• SHMT1 siRNA-Loaded hyperosmotic nanochains for blood-brain/tumor barrier post-transmigration therapy.

  2021cites this paper
• Novel approaches for the delivery of therapeutics in ischemic stroke.

  2020cites this paper
• A Systematic Review of Current Progresses in The Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer's disease.

  2020cites this paper
• A Vaccine for Ischemic Stroke

  2019cites this paper
• Therapeutic Vaccines as Novel Immunotherapy: Biological and Clinical Concepts

  2019cites this paper
• Natural Plasmids in a Swiss Fermented Milk and Colostrum Product assessed by Microbiome Array

  2019cites this paper
• Neuroprotective effect of total flavonoids from Ilex pubescens against focal cerebral ischemia/reperfusion injury in rats

  2017cites this paper
• Anatomical, Biological, and Surgical Features of Basal Ganglia

  2017cites this paper
• DNA Vaccination Associated with Eliminating Inheritance Risks during Embryo Development: A Review

  2016cites this paper
• Pathological and clinical aspects of alpha/beta synuclein in Parkinson’s disease and related disorders

  2016cites this paper
• Active immunization therapies for Parkinson's disease and multiple system atrophy

  2016cites this paper
• Overexpression of hepatocyte growth factor in SBMA model mice has an additive effect on combination therapy with castration.

  2015cites this paper
• The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.

  2015cites this paper
• The Development of Small Molecule Angiotensin IV-Based Analogs to Treat Depression

  2015cites this paper
• Hyperosmotic polydixylitol for crossing the blood brain barrier and efficient nucleic acid delivery.

  2015cites this paper
• Research progress of immune tolerance in the treatment of brain injury

  2014cites this paper
• A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents.

  2014cites this paper
• Engineering DNA Vaccines for Cancer Therapy

  2014cites this paper
• In vivo DNA electrotransfer for immunotherapy of cancer and neurodegenerative diseases.

  2013cites this paper
• A Novel Peptide Delivers Plasmids across Blood-Brain Barrier into Neuronal Cells as a Single-Component Transfer Vector

  2013cites this paper
• Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson’s disease

  2013cites this paper
• Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination

  2013cites this paper
• Drug Delivery Systems for the Treatment of Ischemic Stroke

  2013cites this paper
• From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)

  2013cites this paper
• Angiogenesis after plasmid VEGF165 gene transfer in an animal model

  2013cites this paper
• Innate Immune Signaling By, Genetic Adjuvants For, Dna Vaccination

  2013cites this paper
• Importance of the Brain Angiotensin System in Parkinson's Disease

  2012cites this paper
• Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation

  2012cites this paper
• In-vivo gene delivery by sonoporation: recent progress and prospects.

  2012cites this paper
• Current advances in vehicles for brain gene delivery.

  2012cites this paper